12) Medical Diagnostics Response Capability Development
Abstract
Investigate medical diagnostics ubiquitous and comprehensive against chemical and biological threats (including] NTAs, pharmaceutical-based agents, and toxins) by advancing diagnostic innovations. Aligning capabilities with the FDA pipeline and larger industry to ensure medical diagnostics can rapidly adapt to emerging threats and utilize emerging technologies while harvesting and synergizing the immense volume of diagnostic data.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2020
- Source ID
- f73f713fd8a381ee2a4160007aed088d